FAP and neoplasm: For comparison, [68Ga]Ga-DOTAGA-OncoFAP biodistribution demonstrated beneficial tracer kinetics and high uptake in murine FAP-expressing tumor models with high tumor-to-blood ratios of 8.6 ± 5.1 at 1 h and 38.1 ± 33.1 at 3 h p.i. [8] Application of [18F]AlF-NOTA-OncoFAP as a PET/CT imaging agent may result in significant logistical and clinical advantages as a consequence of the imaging characteristic of the isotope.